JPMorgan Chase & Co. - Net Worth and Insider Trading

JPMorgan Chase & Co. Net Worth

The estimated net worth of JPMorgan Chase & Co. is at least $198 Million dollars as of 2025-05-09. JPMorgan Chase & Co. is the 2201 Interest of corporation controlled by you of Shanghai INT Medical Instruments Co Ltd and owns about 7,467,980 shares of Shanghai INT Medical Instruments Co Ltd (HKSE:01501) stock worth over $198 Million. Details can be seen in JPMorgan Chase & Co.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that JPMorgan Chase & Co. has not made any transactions after 2025-04-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of JPMorgan Chase & Co.

JPMorgan Chase & Co. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, JPMorgan Chase & Co. owns 1 companies in total, including Shanghai INT Medical Instruments Co Ltd (HKSE:01501) .

Click here to see the complete history of JPMorgan Chase & Co.’s form 4 insider trades.

Insider Ownership Summary of JPMorgan Chase & Co.

Ticker	Company	Transaction Date	Type of Owner
HKSE:01501	Shanghai INT Medical Instruments Co Ltd	2025-04-10	2106 Person having a security interest in shares

JPMorgan Chase & Co. Latest Holdings Summary

JPMorgan Chase & Co. currently owns a total of 1 stock. JPMorgan Chase & Co. owns 7,467,980 shares of Shanghai INT Medical Instruments Co Ltd (HKSE:01501) as of April 7, 2025, with a value of $198 Million.

Latest Holdings of JPMorgan Chase & Co.

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:01501	Shanghai INT Medical Instruments Co Ltd	2025-04-07	7,467,980	26.55	198,274,869

Holding Weightings of JPMorgan Chase & Co.

JPMorgan Chase & Co. Form 4 Trading Tracker

According to the SEC Form 4 filings, JPMorgan Chase & Co. has made a total of 24 transactions in Shanghai INT Medical Instruments Co Ltd (HKSE:01501) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Shanghai INT Medical Instruments Co Ltd is the sale of 6,102,147 shares on April 7, 2025, which brought JPMorgan Chase & Co. around $159 Million.

Insider Trading History of JPMorgan Chase & Co.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

JPMorgan Chase & Co. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

JPMorgan Chase & Co. Ownership Network

Ownership Network List of JPMorgan Chase & Co.

No Data

Ownership Network Relation of JPMorgan Chase & Co.

JPMorgan Chase & Co. Owned Company Details

What does Shanghai INT Medical Instruments Co Ltd do?

Who are the key executives at Shanghai INT Medical Instruments Co Ltd?

JPMorgan Chase & Co. is the 2106 Person having a security interest in shares of Shanghai INT Medical Instruments Co Ltd. Other key executives at Shanghai INT Medical Instruments Co Ltd include 2201 Interest of corporation controlled by you China Orient Asset Management (international) Holding Limited , 2202 Interest of your spouse Zhao Wei , and 2201 Interest of corporation controlled by you Wang Kai .

Shanghai INT Medical Instruments Co Ltd (HKSE:01501) Insider Trades Summary

Over the past 18 months, JPMorgan Chase & Co. made 6 insider transaction in Shanghai INT Medical Instruments Co Ltd (HKSE:01501) with a net sale of 0. Other recent insider transactions involving Shanghai INT Medical Instruments Co Ltd (HKSE:01501) include a net sale of 2,125,000 shares made by Zhao Wei , a net sale of 2,125,000 shares made by Ningbo Huaige Health Investment Management Partnership (limited Partnership) , and a net sale of 2,125,000 shares made by Wang Kai .

In summary, during the past 3 months, insiders sold 5,195,000 shares of Shanghai INT Medical Instruments Co Ltd (HKSE:01501) in total and bought 40,000 shares, with a net sale of 5,155,000 shares. During the past 18 months, 11,425,000 shares of Shanghai INT Medical Instruments Co Ltd (HKSE:01501) were sold and 96,000 shares were bought by its insiders, resulting in a net sale of 11,329,000 shares.

Shanghai INT Medical Instruments Co Ltd (HKSE:01501)'s detailed insider trading history can be found in Insider Trading Tracker table.

Shanghai INT Medical Instruments Co Ltd Insider Transactions

No Available Data

JPMorgan Chase & Co. Mailing Address

Above is the net worth, insider trading, and ownership report for JPMorgan Chase & Co.. Currently GuruFocus does not have mailing address information for JPMorgan Chase & Co..

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.